CONMED
CNMD
228 hedge funds and large institutions have $1.69B invested in CONMED in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 96 increasing their positions, 75 reducing their positions, and 65 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 75
0.69% more ownership
Funds ownership: 103.01% → 103.7% (+0.69%)
14% less funds holding
Funds holding: 264 → 228 (-36)
29% less call options, than puts
Call options by funds: $2.57M | Put options by funds: $3.59M
48% less capital invested
Capital invested by funds: $3.27B → $1.69B (-$1.58B)
51% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 65
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$34.3M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$21M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$19.5M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$16.6M |
| 5 |
Renaissance Technologies
New York
|
+$14.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$65.1M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$44.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$44.3M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$28M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$19.2M |
CNMD Hedge Fund Activity: Q1 2020 in Review
228 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q1 2020, worth a combined $1.69B — down 48% from $3.27B a quarter earlier.
Sellers outnumbered buyers: 65 funds closed out of CNMD and 32 opened new positions — a net loss of 33 holders — while 75 trimmed existing stakes and 96 added.
The largest buyer was Point72 Asset Management, adding an estimated $34.3M. The largest seller was Capital Research Global Investors, cutting an estimated $65.1M.
- 228 institutional investors held CONMED (CNMD) as of Q1 2020, down from 264 in Q4 2019.
- Funds reported $1.69B of CONMED stock for Q1 2020, down 48% quarter-over-quarter.
- 32 funds opened new CONMED positions in Q1 2020 and 65 closed out, a net change of -33 holders.
- The largest CONMED buyer in Q1 2020 was Point72 Asset Management, an estimated $34.3M added.
- The largest CONMED seller in Q1 2020 was Capital Research Global Investors, an estimated $65.1M sold.
Based on aggregated 13F filings for Q1 2020.